Personalized Medicine and the Patient
November 14 – 15, 2022 • Hotel Commonwealth, Boston, MA
Research commissioned by the Personalized Medicine Coalition shows that only 22 percent of health care providers are maximizing the benefits of personalized medicine to improve patient care. PMC is organizing Personalized Medicine and the Patient to explore best practices and policies designed to increase the field’s clinical impact with attention to patients’ priorities for the future of health and medicine.
Featured Speakers
Rachel Brummert
Communications Lead, American Society of Pharmacovigilance
Patient harmed by severe side effects of antibiotic
Donna R. Cryer, J.D.
President, CEO, Global Liver Institute
27-year liver transplant recipient
Geoffrey Ginsburg, M.D., Ph.D.
Chief Medical and Scientific Officer
All of Us Research Program, U.S. National Institutes of Health
Robert C. Green, M.D.
Professor of Medicine (Genetics, Director, Genomes2People Research
Harvard Medical School
Candace Henley
Founder, Blue Hat Foundation
Diagnosed with colorectal cancer in 2003
Howard McLeod, Pharm.D.
Executive Clinical Director, Precision Health
Intermountain Healthcare
Siddhartha Mukherjee, M.D., D.Phil.
Assistant Professor of Medicine
Columbia University
Julia Vitarello
Founder, CEO, Mila’s Miracle Foundation; Co-Founder, N=1 Collaborative
Mila's mom
Timothy Yu, M.D., Ph.D.
Co-Founder, N=1 Collaborative; Staff Physician, Investigator;
Associate Professor, Harvard Medical School
Boston Children’s Hospital
Supporters
